Xiamen Amoytop Biotech: Announcement on the approval of the drug clinical trial approval letter for the newly approved indications of Pegintron.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.